These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3547726)

  • 61. [Combination therapy of oropharyngeal and hypopharyngeal cancer: present status and outlook].
    Sauer R; Schwab W
    Sonderb Strahlenther Onkol; 1987; 81():166-70. PubMed ID: 3824127
    [No Abstract]   [Full Text] [Related]  

  • 62. [Radio-hyperthermia in oro- and hypopharyngeal cancer].
    Herbst M
    Sonderb Strahlenther Onkol; 1987; 81():114-21. PubMed ID: 3824123
    [No Abstract]   [Full Text] [Related]  

  • 63. [Oro- and hypopharyngeal cancer: the Basle concept of therapy].
    Wey W; Hünig R; Roth J; Walther E
    Sonderb Strahlenther Onkol; 1987; 81():48-55. PubMed ID: 3824132
    [No Abstract]   [Full Text] [Related]  

  • 64. Monoclonal antibody therapy of cancer.
    Weiner LM
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):43-51. PubMed ID: 10561017
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug-conjugated monoclonal antibodies for the treatment of cancer.
    Lambert JM
    Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Targeting of antitumor drugs with monoclonal antibodies].
    Monneret C; Florent JC
    Bull Cancer; 2000 Nov; 87(11):829-38. PubMed ID: 11125291
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of chemotherapy for advanced oro and hypopharyngeal cancer.
    Kohno N
    Auris Nasus Larynx; 2004 Jun; 31(2):113-8. PubMed ID: 15121218
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined modality therapy for laryngeal and hypopharyngeal cancer.
    Sannazzari GL; Gabriele P; Redda MG; Verna R
    Rays; 1997; 22(3):360-71. PubMed ID: 9446940
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects.
    Strome SE; Sausville EA; Mann D
    Oncologist; 2007 Sep; 12(9):1084-95. PubMed ID: 17914078
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Monoclonal antibody therapy of chronic lymphocytic leukemia.
    Mavromatis B; Cheson BD
    J Clin Oncol; 2003 May; 21(9):1874-81. PubMed ID: 12721266
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antibodies and hematologic malignancies.
    Smith MR
    Cancer J; 2008; 14(3):184-90. PubMed ID: 18536558
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development trends for monoclonal antibody cancer therapeutics.
    Reichert JM; Valge-Archer VE
    Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Advanced hypopharyngeal cancer: functional surgery, chemotherapy and monoclonal antibodies].
    Zenner HP; Herrmann IF
    Sonderb Strahlenther Onkol; 1987; 81():158-60. PubMed ID: 3547726
    [No Abstract]   [Full Text] [Related]  

  • 74. Options for preserving the larynx in patients with advanced laryngeal and hypopharyngeal cancer.
    Wolf GT
    Ear Nose Throat J; 2001 Dec; 80(12):897-901. PubMed ID: 11775526
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Monoclonal antibodies for therapy of human malignant tumours.
    Bergh JC
    Eur J Surg Suppl; 1991 May; (561):59-64. PubMed ID: 1720051
    [No Abstract]   [Full Text] [Related]  

  • 76. Squamous cell carcinoma of the oropharynx and hypopharynx.
    Lin DT; Cohen SM; Coppit GL; Burkey BB
    Otolaryngol Clin North Am; 2005 Feb; 38(1):59-74, viii. PubMed ID: 15649499
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.